Storage and handling
Restricted Drug (California) - Use Only as Directed Store at Controlled Room Temperature, 20° to 25°C (68° to 77°F)
Restricted Drug (California) - Use Only as Directed Store at Controlled Room Temperature, 20° to 25°C (68° to 77°F)
NDC 23243-4240-2
LINCOMYCIN-SPECTINOMYCIN
WATER SOLUBLE POWDER
Antibacterial and Antimycoplasmal
CAUTION: Federal law restricts this drug to
use by or on the order of a licensed veterinarian.
FOR USE IN CHICKENS ONLY
This packet contains:
Lincomycin hydrochloride, equivalent to lincomycin ...... 16.7 grams
Spectinomycin dihydrochloride pentahydrate,
equivalent to spectinomycin.................33.3 grams
Total Antibiotic Activity 50.0 grams Approved by FDA under ANADA # 200-407
NET WEIGHT: 2.65 oz (75 grams)
Manufactured for Huvepharma, Inc.
Peachtree City, Georgia 30269
Made in Bulgaria ® Registered Trademark of Huvepharma, Inc. LOT EXP.
DIRECTIONS FOR USE
INDICATIONS AND USAGE: For use in chickens up to 7 days of age as an aid in the control of:
Airsacculitis caused by either Mycoplasma synoviae or Mycoplasma gallisepticum susceptible to lincomycin-spectinomycin.
Complicated Chronic Respiratory Disease (Air Sac Infection) caused by Escherichia coli and M. gallisepticum susceptible
to lincomycin-spectinomycin.
DOSAGE AND ADMINISTRATION
Dosage: Provide 2 grams (g) antibiotic activity per gallon of drinking water. Administer as the sole source of water for the first 5 to 7 days of life.
Administration:
| Amount of Lincomycin-Spectinomycin | Amount of Drinking Water |
| 1 packet | 25 gallons |
| For proportioners delivering 1 ounce of solution per gallon of drinking water, dissolve contents of 5 packets in each gallon of proportioner solution. | |
IMPORTANT: Chickens should consume water at the following approximate rate to ensure intake of the required dose of lincomycin-spectinomycin indicated:
| Broilers and Layer Replacements (Light and Heavy) | ||
| Age (Weeks) | Daily Water Intake (Gallons/1000) | Dosage (mg Antibiotic/lb) |
| 1 | 5 | 50-65 |
PRECAUTION: Discard medicated drinking water daily and replace with fresh medicated drinking water.
WARNING: Not for Use in Humans
Keep Out of Reach of Children
CONTACT INFORMATION:
To report suspected adverse drug events, for technical assistance or to obtain a
copy of the Safety Data Sheet (SDS), contact Huvepharma, Inc. at 1-877-994-4883
or
www.huvepharma.us.
For additional information about adverse drug experience reporting for animal drugs,
contact FDA at 1-888-FDA-VETS or
www.fda.gov/reportanimalae
Restricted Drug (California) - Use Only as Directed
Store at Controlled Room Temperature, 20° to 25°C (68° to 77°F)
Manufactured For: Huvepharma, Inc. Peachtree City, GA 30269
Made in Bulgaria
® Registered Trademark of Huvepharma, Inc.
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 673b6365-42b3-455d-b9d1-7358f1db4536 | Product name | 4 | 20231212 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 23243-4240-2 | Lincomycin-SpectinomycinWater Soluble Powder | 75 g in 1 PACKET | POWDER, FOR SOLUTION | 75 | 4 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 23243-4240 | LINCOMYCIN-SPECTINOMYCIN WATER SOLUBLE POWDER (LINCOMYCIN-SPECTINOMYCIN) POWDER, FOR SOLUTION [HUVEPHARMA, INC] | 4 | 1 package rows | 20250418_3e8710f8-d1e2-45ae-ac69-a97e0a35a655.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 23243-4240 | 23243-4240-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LINCOMYCIN HYDROCHLORIDE | M6T05Z2B68 | ACTIM |
| SPECTINOMYCIN HYDROCHLORIDE | HWT06H303Z | ACTIM |
| Sucrose | C151H8M554 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LINCOMYCIN | LINCOMYCIN HYDROCHLORIDE | Henry Schein, Inc. | a7692968-7ac8-48ab-89a4-27c7803e31f4 | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | LINCOMYCIN HYDROCHLORIDE |
| Lincocin | LINCOMYCIN HYDROCHLORIDE | Pharmacia & Upjohn Company LLC | c01906fa-2c73-4c13-9765-2fd06628d263 | 2025-03-10 | Boxed warning, Warnings, Adverse reactions | LINCOMYCIN HYDROCHLORIDE |
| Lincomycin | LINCOMYCIN HYDROCHLORIDE | PAI Holdings, LLC dba PAI Pharma | 23f9608c-3126-35db-e063-6294a90af054 | 2024-10-08 | Boxed warning, Warnings, Adverse reactions | LINCOMYCIN HYDROCHLORIDE |
| Lincomycin | LINCOMYCIN HYDROCHLORIDE | Sagent Pharmaceuticals | 75e149cc-b668-427e-bae7-a0d215e4fb7a | 2023-03-20 | Boxed warning, Warnings, Adverse reactions | LINCOMYCIN HYDROCHLORIDE |
| Lincomycin | LINCOMYCIN HYDROCHLORIDE | XGen Pharmaceuticals DJB, Inc. | 61f4851d-d919-400d-912a-05eb9dca11d4 | 2022-10-14 | Boxed warning, Warnings, Adverse reactions | LINCOMYCIN HYDROCHLORIDE |
| lincomycin hydrochloride | LINCOMYCIN HYDROCHLORIDE | Gland Pharma Limited | c2b5be20-cc6f-4221-9d3e-3f8b5886cd05 | 2022-09-28 | Boxed warning, Warnings, Adverse reactions | LINCOMYCIN HYDROCHLORIDE |
Adverse event summaries are temporarily unavailable. Other product information remains available.